Identification and validation of a novel signature based on T cell marker genes to predict prognosis, immunotherapy response and chemotherapy sensitivity in head and neck squamous carcinoma by integrated analysis of single-cell and bulk RNA-sequencing.
Heliyon
; 9(11): e21381, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37954266
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Heliyon
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: